Therefore, inhibition of the NLRP3 inflammasome could potentially lead to a corresponding decrease in the levels of strongly pro-inflammatory cytokines, especially IL-1β, which is released from pyroptotic macrophages and monocytes in large amounts in COVID-19 ARDS [23,51,69,70]. Here, NLRP3 is linked to acute respiratory distress syndrome.